Annual General Meeting of SKAN Group AG approves all proposals

07.05.25 17:49 Uhr

Werte in diesem Artikel
Aktien

68,90 CHF -0,70 CHF -1,01%

SKAN AG / Key word(s): AGMEGM
Annual General Meeting of SKAN Group AG approves all proposals

07.05.2025 / 17:49 CET/CEST

Wer­bung


Media Information
 

Annual General Meeting of SKAN Group AG approves all proposals

Allschwil, 7 May 2025 – The Annual General Meeting of SKAN Group AG was held today in Allschwil. At the General Meeting a total of 85.75% of the share capital entitled to vote was represented.

The Annual General Meeting approved all proposals of the Board of Directors. In particular, it approved the distribution of CHF 0.40 per dividend-bearing share, consisting of an ordinary dividend of CHF 0.20 per share and a tax-free distribution from capital reserves of CHF 0.20 per share. The distribution will be made as from 13 May 2025.

Wer­bung

The Board members standing for re-election Oliver Baumann, Cornelia Gehrig, Thomas Huber, Beat Lüthi, Gregor Plattner and Patrick Schär have been confirmed for another one-year term. Beat Lüthi was re-elected as Chairman of the Board of Directors.

The consultative votes on the remuneration report and the report on non-financial matters were also approved.

The next Annual General Meeting of SKAN Group AG will take place on 7 May 2026.


Distribution dates:

Wer­bung

  • Ex-date: 9 May 2025
  • Record date: 12 May 2025
  • Payment date: 13 May 2025


Contacts:

Thomas Balmer, ir@skan.com, +41 79 703 87 28
Alexandre Müller, ir@skan.com, +41 79 635 64 13


Financial calendar:

19 August 2025 Publication Half-Year Results 2025
24 March 2026 Publication Annual Results 2025
7 May 2026 Annual General Meeting 2026

 

SKAN – together always one step ahead

SKAN is a pioneer in the field of aseptic and aseptic-toxic manufacturing processes for the (bio)pharmaceutical industry. The company is the market and technology leader for high-quality, process-critical isolator systems for filling drugs according to strict sterility standards. In addition, the company offers its customers process support, services and consumables. Innovative solutions and an efficient life-cycle support organisation make SKAN an important partner for the pharmaceutical and biotech industry, CMOs (Contract Manufacturing Organisations) and research laboratories worldwide. Founded in 1968, SKAN today employs approximately 1500 people. More than half of them work at the Allschwil headquarters in the Life Sciences Hub of the Basel region. The other employees are located among the subsidiaries in Switzerland, Germany, Belgium, Japan, the USA and Brazil.



End of Media Release


Language: English
Company: SKAN AG
Kreuzstrasse 5
4123 Allschwil
Switzerland
Phone: +41 43 268 32 32
E-mail: info@skan.com
ISIN: CH0013396012
Valor: 1339601
Listed: SIX Swiss Exchange
EQS News ID: 2132518

 
End of News EQS News Service

2132518  07.05.2025 CET/CEST

Ausgewählte Hebelprodukte auf SKAN

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf SKAN

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu SKAN

Wer­bung